GSK
GSK plc
$50.41
-0.18%
2026-05-08
About GSK plc
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
Key Fundamentals
P/E Ratio
13.06
Forward P/E
9.64
EPS (TTM)
$3.86
ROE
40.9%
Revenue Growth (YoY)
1.5%
Profit Margin
17.8%
Debt/Equity
109.70
Dividend Yield
3.6%
Price/Book
4.18
Beta
0.30
Market Cap
$101.24B
Avg Volume (10D)
4.9M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$61.70
60D Low
$49.99
Avg Volume
4.5M
Latest Close
$50.41
Get breakout alerts for GSK
Sign up for Breakout Scanner to receive daily notifications when GSK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
GSK plc (GSK) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors GSK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. GSK operates in the Healthcare sector within the Drug Manufacturers - General industry. Data is provided for informational purposes only and does not constitute financial advice.